BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27074491)

  • 21. MR Spectroscopy for Differentiating Benign From Malignant Solid Adnexal Tumors.
    Ma FH; Qiang JW; Cai SQ; Zhao SH; Zhang GF; Rao YM
    AJR Am J Roentgenol; 2015 Jun; 204(6):W724-30. PubMed ID: 26001263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
    Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
    Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Observation of intramyocellular lipids by 1H-magnetic resonance spectroscopy.
    Boesch C; Kreis R
    Ann N Y Acad Sci; 2000 May; 904():25-31. PubMed ID: 10865706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration.
    Mahon MM; Williams AD; Soutter WP; Cox IJ; McIndoe GA; Coutts GA; Dina R; deSouza NM
    NMR Biomed; 2004 Feb; 17(1):1-9. PubMed ID: 15011245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo 1H MRS of human gallbladder bile at 3 T in one and two dimensions: detection and quantification of major biliary lipids.
    Mohajeri S; Ijare OB; Bezabeh T; King SB; Thomas MA; Minuk G; Lipschitz J; Kirkpatrick I; Smith M; Smith IC
    NMR Biomed; 2014 Oct; 27(10):1192-202. PubMed ID: 25132620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Feasibility of proton magnetic resonance spectroscopy of the myocardium in vivo].
    Wu J; Yang L; Yang CH; Yang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Oct; 30(10):2295-7. PubMed ID: 20965829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterisation of musculoskeletal tumours by multivoxel proton MR spectroscopy.
    Patni RS; Boruah DK; Sanyal S; Gogoi BB; Patni M; Khandelia R; Gogoi N
    Skeletal Radiol; 2017 Apr; 46(4):483-495. PubMed ID: 28188338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-vivo proton magnetic resonance spectroscopy in adnexal lesions.
    Cho SW; Cho SG; Lee JH; Kim HJ; Lim MK; Kim JH; Suh CH
    Korean J Radiol; 2002; 3(2):105-12. PubMed ID: 12087200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of single voxel 1H MR spectroscopy of bone tumors: differentiation of benign from malignant tumors.
    Zhang J; Cheng K; Ding Y; Liang W; Ding Y; Vanel D; Cheng X
    Eur J Radiol; 2013 Dec; 82(12):2124-8. PubMed ID: 22169357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Could lipid CH2/CH3 analysis by in vivo 1H MRS help in differentiation of tumor recurrence and post-radiation effects?
    Matulewicz Ł; Sokół M; Wydmański J; Hawrylewicz L
    Folia Neuropathol; 2006; 44(2):116-24. PubMed ID: 16823694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Vivo
    Muñoz-Hernández MC; García-Martín ML
    Methods Mol Biol; 2018; 1718():151-167. PubMed ID: 29341008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fully navigated 3 T proton magnetic resonance spectroscopy of liver metastases with inner-volume saturation.
    Reischauer C; Hock A; Kolokythas O; Binkert CA; Gutzeit A
    Abdom Radiol (NY); 2017 Nov; 42(11):2615-2622. PubMed ID: 28523414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [In vivo proton MR spectroscopy of normal liver parenchyma: technique and results].
    Müller C; Hübner F; Bisdas S; Herzog C; Hammerstingl RM; Ackermann H; Vorbuchner M; Vogl TJ
    Rofo; 2006 Nov; 178(11):1128-36. PubMed ID: 17128381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in the variability of cerebral proton magnetic resonance spectroscopy (1H-MRS) measurements within three HIV-infected cohorts.
    Vigneswaran S; Rojas JH; Garvey L; Taylor-Robinson S; Winston A
    Neuroradiol J; 2015 Dec; 28(6):545-54. PubMed ID: 26493269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results.
    Wang CK; Li CW; Hsieh TJ; Chien SH; Liu GC; Tsai KB
    Radiology; 2004 Aug; 232(2):599-605. PubMed ID: 15286325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intramyocellular lipid quantification: repeatability with 1H MR spectroscopy.
    Torriani M; Thomas BJ; Halpern EF; Jensen ME; Rosenthal DI; Palmer WE
    Radiology; 2005 Aug; 236(2):609-14. PubMed ID: 16040916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic characterization of all-trans-retinoic acid (ATRA)-induced craniofacial development of murine embryos using in vivo proton magnetic resonance spectroscopy.
    Qin F; Shen Z; Peng L; Wu R; Hu X; Zhang G; Tang S
    PLoS One; 2014; 9(5):e96010. PubMed ID: 24816763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic approach for tumor delineation in glioma surgery: 3D MR spectroscopy image-guided resection.
    Zhang J; Zhuang DX; Yao CJ; Lin CP; Wang TL; Qin ZY; Wu JS
    J Neurosurg; 2016 Jun; 124(6):1585-93. PubMed ID: 26636387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantification of Bone Marrow Involvement in Treated Gaucher Disease With Proton MR Spectroscopy: Correlation With Bone Marrow MRI Scores and Clinical Status.
    Jaramillo D; Bedoya MA; Wang DJ; Pena AH; Delgado J; Jaimes C; Ho-Fung V; Kaplan P
    AJR Am J Roentgenol; 2015 Jun; 204(6):1296-302. PubMed ID: 26001241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner.
    Kuo YT; Li CW; Chen CY; Jao J; Wu DK; Liu GC
    J Magn Reson Imaging; 2004 May; 19(5):598-604. PubMed ID: 15112309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.